REFERENCES
- Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia. J Urol 1984; 132: 474–479.
- Brendler H. Benign prostatic hyperplasia: natural history. In: Benign Prostatic Hyperplasia. Grayhock JT, Wilson JD, Scherbenske MJ (eds.). Bethesda, Maryland. NIH, 1975, pp. 101–103.
- Coffey DS, Walsh PC. Clinical and experimental studies of benign prostatic hyperplasia. Urol Clin North Am 1990; 17: 461–475.
- Collins GN, Lee RH, McKelvie GB, Rogers AC, Hehir M. Relationship between prostate specific antigen, prostate volume and age in the benign prostate. Br J Urol 1993; 71: 445–450.
- Finasteride Study Group: Finasteride (MK-906) in treatment of benign prostatic hyperplasia. Prostate 1993; 22: 291–299.
- Gup DI, Shapiro E, Baumann N, et al. Automatic receptors in human prostate adenoma. J Urol 1990; 143: 179–185.
- Higgins C, Stevens RA. The effect of castration on benign prostatic hypertrophy of the prostate in war. J Urol 1940; 43: 705–714.
- Hosni Y, Marutsuka K, Asada Y, Ide H, Nishe S, Osada Y. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994; 25: 91–96.
- Lepor H, Machi GM. The relative efficacy of terazosin versus terazosin and flutamide for asymptomatic BPH. Prostate 1992; 20: 89–95.
- Lepor H, Wang B, Shapiro E. Relationship between prostatic epithelial volume and serum prostate specific antigen levels. Urology 1994; 44: 199–205.
- Oesterling JE, Jacobsen SE, Chute CG, et al. Serum prostate specific antigen in a community-based population of healthy men. JAMA 1993; 270: 860–864.
- Roehrborn CG. The assessment of medical treatment for benign prostatic hyperplasia. In: Kurth K, Newling WW (eds.): Benign Prostatic Hyperplasia. New York, Wiley-Liss Inc., 1994; pp. 175–190.
- Shapiro E, Hartano Y, Lepor H. The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle. Prostate 1992; 21: 297–307.
- Shapiro E, Hartano Y, Lepor H. Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis. J Urol 1992; 147: 1167–1170.
- Weber JP, Oesterling JE, Peters CA, et al. The influence of reversible androgen deprivation on serum prostate specific antigen levels in men with benign prostatic hyperplasia. J Urol 1989; 141: 987–992.